TAZORAC (Allergan, Inc.)
Welcome to the PulseAid listing for the TAZORAC drug offered from Allergan, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | tazarotene |
SUBSTANCE NAME: | TAZAROTENE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
ROUTE: | CUTANEOUS |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-08-01 |
END MARKETING DATE: | 0000-00-00 |
TAZORAC HUMAN PRESCRIPTION DRUG Details:
Item Description | TAZORAC from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/g) |
START MARKETING DATE: | 1997-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0023-0042_ca6ba093-8b7e-455a-b9ab-74e249420add |
PRODUCT NDC: | 0023-0042 |
APPLICATION NUMBER: | NDA020600 |
Other TAZAROTENE Pharmaceutical Manufacturers / Labelers: